Leaflet BIO-Europe 2013

WHERE THE GLOBAL BIOTECH INDUSTRY COMES TO PARTNER
BIO-EUROPE
SPRING 2013
7th Annual International Partnering Conference
®
Online
pa
star ts Ja r tnering
nuary 2
8
MARCH 11–13, 2013
BARCELONA, SPAIN
Centre Convencions Internacional Barcelona (CCIB)
www.ebdgroup.com/bes
Producer
Supported by
Follow this event:
Search by: #BES13
Host Sponsors
ABOUT THE CONFERENCE
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues
the tradition of providing life science companies with high caliber partnering opportunities.
BIO-Europe Spring brings together the global biotech industry’s top dealmakers, from large biotech and pharma
companies to financiers and innovative start-ups. Powered by partneringONE®, EBD Group’s sophisticated, webbased partnering system, the event enables delegates to efficiently identify, meet and get partnerships started with
companies across the life science value chain.
BIO-EUROPE SPRING FEATURES
PARTNERING
Prescheduled one-to-one
meetings with investors,
pharmaceutical and biotechnology companies
PRESENTATIONS
Presentations by leading
innovators in the life
science industry
BIO-EUROPE SPRING 2012
HIGHLIGHTS:
•11,172 one-to-one meetings
• 2,508 licensing opportunities posted
• 2,157 delegates
• 1,304 companies
•135 company presentations
• 67 exhibitors
• 44 countries represented
• 18 workshops and panels
SESSIONS
The latest industry trends
in workshops and expert
panels
EXHIBITION
High traffic exhibition
showcasing products,
services and
technologies
PARTNERING AT BIO-EUROPE SPRING
Powered by
Partnering at BIO-Europe Spring is powered by partneringONE®, the most advanced partnering system for helping life
science delegates to easily meet and conduct business. This sophisticated, web-based partnering system enables
delegates to screen potential partners, pre-arrange multiple meetings and manage their schedule for optimal productivity.
With partneringONE you can:
¢ Create a profile
Import your profile from a previous partnering event or create a new one to highlight yourself, your company and
licensing opportunities so other participants can find you. Others will use your profile to evaluate your meeting requests.
¢ Request to meet
Search and bookmark companies, participants and partnering opportunities of interest and send up to 150 requests for
one-to-one meetings.
¢ Manage your activities
Accept or decline requests from others, and manage your meeting schedule for all your accepted requests.
¢ partneringONE is web-based, there is nothing to download to your computer.
PROFILE OF PARTICIPANTS
BIO-Europe Spring attracts international executives from:
¢ Established and emerging biotech companies
¢ Private investors including venture capital and private equity
¢ Institutional financial firms
¢ Companies developing companion diagnostics
¢ Pharmaceutical companies
¢ Other industry related service companies
Industry
Position
Biotech 36 %
Pharma 21 %
Finance 4 %
CRO, CMO, Service, Law,
Consulting 29 %
¢ Others (Government, Agencies,
Associations, Press) 10 %
¢ Top Management (CEO, CSO, CFO,
President, Managing Director) 31 %
¢ Senior Management (Director, VP) 43 %
¢ Middle Management 26 %
¢
¢
¢
¢
Region
¢ Europe 70 %
¢ North America 19 %
¢ Rest of World 11 %
based on BIO-Europe Spring 2012
PRELIMINARY PROGRAM
SUNDAY, MARCH 10
15:00–19:00 J oin guided tours to Barcelona’s main scientific infrastructures and famous monuments, hosted by Biocat in
­collaboration with Parc de l’ALBA and RJ-Biotech Services. Find out more: www.ebdgroup.com/bes/program
19:00 Registration opens / 19:00–21:30 Welcome Reception
MONDAY, MARCH 11
07:45 Registration and Exhibition open
09:00–10:30 Parallel Workshops
- Exploring alternative financing models
- Recognizing and avoiding mistakes that can cost you the deal
- Personalized oncology and next gen cancer drug development
- Is there a downward trend in diabetes treatment innovation? And if so, what can we do about it?
10:45–12:30 Welcome and Opening Remarks
Opening Plenary Session
- Is pharma taking over the role of VC?
13:30–18:15 Parallel Panel Discussions
Business Development
- Examining major deals of the past year
- Going public: A review of 2012’s IPOs
- How do you operationalize external R&D? Best deal structures?
- Early stage drug discovery
13:30–18:30
One-to-one
Meetings
In the Spotlight
- Alzheimer’s: How to fund late stage, large scale trials
- Austerity for whom? Market access in Europe and its effect on dealmaking
- Stem cells in drug discovery: New opportunities for biotech-pharma collaboration
- Cancer immunotherapies: Overcoming the key challenges to commercialization
Therapeutic Insight by Defined Health
- Balancing scientific and commercial risk in the pursuit of relevance
- Therapeutic Insight: Oncology
- Therapeutic Insight: Antibiotics
- Therapeutic Insight: Orphan CNS diseases
Pharma Presentations
19:00–22:30 Evening Event
TUESDAY, MARCH 12
07:45 Registration and Exhibition open
09:00–17:00
Company Presentations
08:00–18:30
One-to-one Meetings
19:00–22:30 Evening Event
WEDNESDAY, MARCH 13
07:45 Registration and Exhibition open
09:00–13:00
Company Presentations
08:00–17:00
One-to-one Meetings
16:30 Closing Reception
SPONSORING BIO-EUROPE SPRING
Sponsorship opportunities are available for companies seeking maximum exposure to BIO-Europe Spring
participants. Through an understanding of your corporate objectives, we can develop a package of benefits tailored
to meet your individual needs and budget. Contact us to discuss your ideas!
Katharina Schropp | +41 43 500 3545 | [email protected]
EXHIBITING AT BIO-EUROPE SPRING
BIO-Europe Spring’s international exhibition is a high visibility showcase for companies in the life science industry.
Located centrally to the partnering booths and lounge areas, the exhibition hall serves as a hub for informal meetings
and networking.
For more information contact:
Sanne Dech | +49 7132 3430 98 | [email protected]
REGISTRATION FEES*
Registration Fee (after January 18, 2013) ................. EUR 1,990 / USD 2,290
Onsite Registration Fee (after March 7, 2013) .......... EUR 2,090 / USD 2,390
For more information and registration visit www.ebdgroup.com/bes
* The registration fees are excluding VAT; VAT will be added as applicable.
USD fees apply to North American companies only.
Therapeutic Insight by Defined Health is a forum for
industry executives to access an unparalleled
understanding of transformational challenges and
opportunities across the industry and within selected
disease and platform technology areas. Therapeutic
Insight sessions connect the “big picture” with the real
world of drug development and commercialization,
uniting “30,000 foot” viewpoints with tangible,
ground-level discussions of pipelines, market and
competitive dynamics, development, regulatory and
market access issues, evolving standards of care
and epidemiology. In addition to an updated
presentation focused on “Proof of Relevance” (as
opposed to proof of concept) in drug development,
this year’s sessions will explore key dynamics in the
heating up antibiotics space, CNS orphan diseases
and the ever active oncology development arena.
Therapeutic Insight is a perfect way to utilize
BIO-Europe Spring to deliver more meetings, better
informed decisions, and better deals.
SPONSORS AND SUPPORTERS OF BIO-EUROPE SPRING 2013*
* confirmed as of December 20, 2012
Host Sponsors
Platinum Sponsors
Silver Sponsors
Main Media Sponsors
Media Sponsors
SPONSORS OF BIO-EUROPE SPRING 2013
BIO Double Helix Sponsors
BIO Helix Sponsors
Gold Sponsors
Supporters
Return Address:
EBD Group, Inc.
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
BIO-EUROPE SPRING · MARCH 11–13, 2013 · BARCELONA, SPAIN
Contacts:
In Europe:
Manuela Hildebrand
EBD Group
+49 89 2388 7560
[email protected]
In the USA:
Christina Hundschell
EBD Group
+1 760 930 0500
[email protected]
Find out more:
www.ebdgroup.com/bes
© 2012–2013 EBD Group AG